Primary HPV screening for cervical cancer.
Bhatla N, Singhal S.
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:98-108. doi: 10.1016/j.bpobgyn.2020.02.008. Epub 2020 Mar 2.
Digital analysis and quantitative assessment of the cervical surface with dysplasia.
Dushkin AD, Afanasiev MS, Zatevalov AM, Aleshkin VA, Mironov AY, Afanasiev SS, Nesvizhsky YV, Borisova OY, Grishacheva TG, Karaulov AV.
Klin Lab Diagn. 2021 Jul 16;66(7):417-421. doi: 10.51620/0869-2084-2021-66-7-417-421.
Virologic screening.
Schneider A.
Eur J Obstet Gynecol Reprod Biol. 1996 Mar;65(1):61-3. doi: 10.1016/0028-2243(95)02326-n.
Cervical dysplasia and human papillomavirus.
Carmichael JA, Maskens PD.
Am J Obstet Gynecol. 1989 Apr;160(4):916-8. doi: 10.1016/0002-9378(89)90310-4.
Mild cervical dysplasia. Experience in a family planning clinic.
Sondheimer SJ, Casey MV, Rubin M, Mangan C, Atkinson B, Huggins GR.
J Reprod Med. 1983 Jul;28(7):489-95.
Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis.
Steinbeck RG.
Acta Oncol. 1997;36(1):3-12. doi: 10.3109/02841869709100723.
Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count.
Davis AT, Chakraborty H, Flowers L, Mosunjac MB.
Gynecol Oncol. 2001 Mar;80(3):350-4. doi: 10.1006/gyno.2000.6104.
Cervical intraepithelial neoplasia and fecundability: a prospective cohort study.
Kristensen ML, Waldstrøm M, Laursen ASD, Eriksen K, Ulrichsen SP, Hatch EE, Wise LA, Rothman KJ, Sørensen HT, Mikkelsen EM.
Hum Reprod. 2024 Aug 1;39(8):1835-1843. doi: 10.1093/humrep/deae139.
Laser miniconization procedure.
Békássy Z.
Int J Gynaecol Obstet. 1996 Dec;55(3):237-46. doi: 10.1016/s0020-7292(96)02767-1.
Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.
Farley J, Uyehara C, Hashiro G, Belnap C, Birrer M, Salminen E.
Gynecol Oncol. 2004 Feb;92(2):596-602. doi: 10.1016/j.ygyno.2003.10.052.
